Thursday, July 28, 2016

BRIEF-Caladrius Biosciences receives FDA fast track designation

* Caladrius Biosciences receives FDA fast track designation

for CLBS03 to treat recent onset type 1 diabetes

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)